Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 |
filingDate |
2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41593b50fe73412abee4f315814a36f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3aefdbae45ead1a18bca913d2994269 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04287f414bf4a8f5026f50cb69eee69a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e985a185d01c4fe0c755eebc813680ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c9c5eade10edb24180e77f78538806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc7b25c0c3c23f13fd9837678db9eca7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53273976058edc579a9b81056cf21155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9b7e8e845e4810c51f7d9786fc0aab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0d478ea295d72a6872b08e329ed2a1 |
publicationDate |
2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20090056095-A |
titleOfInvention |
A composition for preventing vascular restenosis comprising a cell adhesion factor expression gene inhibitor of vascular endothelial cells and a stent coated therewith |
abstract |
The present invention is to use a substance that inhibits the cell adhesion factor expression gene of vascular endothelial cells in the drug-release stent used for vascular stenosis, more specifically, Shizukaol B, cyclosijukaol A defined by the following Chemical Formulas 1 to 3 And a composition for preventing vascular restenosis and a stent coated with the composition, including an inhibitor of vascular endothelial cell expression gene expression, comprising a compound selected from the group consisting of Shizukaol F.n n n The organ or vascular restenosis prevention composition and stent coated with the same according to the present invention reduce the re-adhesion and infiltration of blood cells such as monocytes, neutrophils and lymphocytes into the blood vessel wall and restenosis caused by various causes after the stent procedure. It is effective to prevent). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115716813-A |
priorityDate |
2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |